Anika Therapeutics, Inc. (ANIK) has a market capitalization of $220.64M and trades at $15.30. The 52-week range is 7.87-15.18.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -20.1, Earnings Per Share (EPS) of $-0.76, annual revenue of $112.82M.
The stock has a beta of 0.28, operates in the Healthcare sector.
